Silver Book Fact

Researchers have found how to manipulate embryonic stem cells to form dopamine-producing brain cells. This new source of cells could someday be used to replace cells lost to Parkinson’s.

Perrier, Anselme L., Viviane Tabar, Tiziano Barberi, Maria E. Rubio, Juan Bruses, Norbert Topf, Neil L. Harrison, and Lorenz Studer. Derivation of Midbrain Dopamine Neurons from Human Embryonic Stem Cells. Proceedings of the National Academy of Sciences. 2004; 101(34): 12543-8. http://www.pnas.org/cgi/content/short/101/34/12543

Reference

Title
Derivation of Midbrain Dopamine Neurons from Human Embryonic Stem Cells
Publication
Proceedings of the National Academy of Sciences
Publication Date
2004
Authors
Perrier, Anselme L., Viviane Tabar, Tiziano Barberi, Maria E. Rubio, Juan Bruses, Norbert Topf, Neil L. Harrison, and Lorenz Studer
Volume & Issue
Volume 101, Issue 34
Pages
12543-8
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • The U.S. Food and Drug Administration has approved 5 drugs for the treatment of Alzheimer’s disease. These drugs have been found to temporarily slow the worsening of Alzheimer’s symptoms for…  
  • A treatment that delayed the age of onset of Alzheimer’s disease by five years would reduce the proportion of Americans age 65 and older with the disease from 10% to…  
  • If the progression of Parkinson’s disease were slowed by 50%, there would be a 35% reduction in excess costs.  
  • Impact of Slowed Progression on Alzheimer’s Disease Growth, Americans Age 65 and Older with Alzheimer’s, 2010-2050  
  • A current drug in development addresses the underlying cause of type 2 diabetes by modulating genes responsible for insulin sensitization.